Marvel Biosciences Corp · TSXV:MRVL

Marvel Biosciences Corp financial statements

Marvel Biosciences Corp's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CAD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue000000
Cost of revenue547.4K302.0K887.5K1.38M613.1K265.2K
Gross profit-547.4K-302.0K-887.5K-1.38M-613.1K-265.2K
Research and development547.4K302.0K887.5K1.38M
Selling, general and administrative920.8K913.4K1.41M1.17M1.25M1.02M
Operating income-1.25M-1.27M-2.25M-2.55M-1.10M-954.8K
Depreciation and amortization0152185413284
EBITDA-2.25M-2.55M-1.10M-954.4K
Interest expense268.0K114.0K38.4K0000
Income before tax-2.21M-1.65M-2.29M-2.55M-3.04M-955.7K
Income tax-151.8K-63.5K
Net income-2.21M-1.65M-2.29M-2.55M-3.04M-955.7K
Earnings per share, basic-0.04-0.04-0.06-0.07-0.09-0.03

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents128.9K345.8K556.6K593.2K2.39M224.8K
Receivables56.4K59.1K35.8K
Current assets326.7K491.3K672.4K913.5K2.47M295.6K171
Property, plant and equipment152337750
Total assets326.7K491.3K672.4K913.5K2.47M296.0K
Accounts payable1.50M1.35M1.21M262.1K1.56K94.2K50.7K
Current liabilities4.33M3.32M1.39M718.0K112.5K177.2K209.3K
Long-term debt1.71M1.00M
Total liabilities4.33M3.32M2.39M718.0K112.5K177.2K
Shareholders' equity-4.01M-2.83M-1.72M195.5K2.36M118.8K
Shares outstanding53.0M44.8M39.8M37.1M32.6M32.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-1.15M-1.18M-1.33M-2.19M-1.37M-538.5K-157.4K
Capital spending000000-1.03K
Free cash flow-1.15M-1.18M-1.33M-2.19M-1.37M-538.5K-158.4K
Cash from investing381.6K381.6K-1.03K
Cash from financing933.4K968.6K1.30M394.0K3.16M763.2K158.6K
Change in cash-216.9K-210.9K-36.6K-1.80M2.17M224.6K171